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Abstract
Purpose—We previously reported on the feasibility of a Web-based system to capture patient-
reported outcomes (PROs) in the immediate postoperative period. The purpose of this study was to 
update the experience of these patients and assess patient and provider satisfaction and feedback 
regarding the system.
Methods—This is a prospective cohort study of patients scheduled to undergo laparotomy for 
presumed gynecologic malignancy. Patients completed a Web-based Symptom Tracking and 
Reporting (STAR) questionnaire preoperatively and weekly during a 6-week postoperative period. 
Email alerts were sent to study nurses when concerning patient responses were entered. The 
patient and the nurse assessments of STAR’s usefulness were measured via an exit survey.
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Results—The study enrolled 96 eligible patients. Of these, 71 patients (74%) completed at least 
four of seven total sessions. Of the patients who completed the exit satisfaction survey, 98% found 
STAR easy to use; 84% found it useful; and 82% would recommend it to other patients. Despite 
positive feedback from patients, clinical personnel found that the STAR system increased their 
current workload without enhancing patient care.
Conclusions—Application of an electronic program for PROs in those recovering from major 
gynecologic cancer surgery is feasible, and acceptable to most patients. While most clinicians did 
not find STAR clinically helpful, the majority of patients reported a positive experience with the 
system and would recommend its use. The program helped many patients feel more empowered in 
their postoperative recovery.
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Gynecologic cancer; Gynecologic surgery; Quality of life; Patient-Reported Outcomes
INTRODUCTION
The NIH, NCI, FDA and numerous other stakeholders have asserted that the impact of 
medical interventions and surgery are best evaluated by patients directly, without filtering by 
clinicians, in the form of patient-reported outcome (PRO) measures [1]. As a result, there 
has been increasing emphasis on the incorporation of PROs into clinical trials and routine 
clinical practice [2, 3]. This is also relevant because the Affordable Care Act (ACA) allows 
for a financial reward, in the form of small bonuses, for providers who provide quality care. 
The ACA also allows for financial penalties for providers who fail to provide quality care. 
Assessment of reward or penalty is based on outcome or performance as measured by a 
quality indicator [4]. Because stakeholders in cancer care agree that the current quality 
metrics are insufficient, some have proposed new models. Many of these, such as the 
National Quality Forum (NQF) model, include PRO measures [5].
Most PRO surveys in cancer patients have been administered at baseline and 3 months post-
treatment [2, 6]. There is limited data regarding PROs in gynecologic cancer patients in the 
immediate 6 weeks following surgery. Collecting PROs during this time period can enrich 
preoperative teaching, help identify complications earlier, and improve symptom control [2]. 
Currently, however, there is not enough data available to determine if patients are able or 
willing to self-report symptoms during this critical period, or if providers find this 
information constructive.
Our previously published pilot study suggested that the use of a Web-based system to 
capture PROs is feasible and highly acceptable by patients in the acute postoperative period 
after major gynecologic surgery[7]. The objectives of this study were to update the 
experience of these patients, and to assess patient and provider satisfaction and feedback 
regarding the system.
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METHODS
This study was approved by the Institutional Review Board (IRB) at Memorial Sloan 
Kettering Cancer Center. The patients, study design, and online platform were previously 
described in a pilot report on the feasibility and acceptability of this Web-based system [7]. 
English-speaking patients 18 years of age and older, who were scheduled to undergo 
laparotomy for presumed or known gynecologic malignancy, were recruited to participate. 
All patients were required to have access to a home computer and a personal email account.
At the time of enrollment, patients were trained in the use of the Symptom Tracking and 
Reporting (STAR) system. They were asked to complete a baseline information 
questionnaire and seven STAR surveys. This paper questionnaire was administered by the 
consenting professional immediately after consent was obtained. It measures variables that 
we expected to be predictors of STAR utilization, including age, education level, 
employment status, and prior internet experience. Demographic data was gathered from the 
electronic medical records. The surveys consisted of the patient adaptation of the NCI 
Common Terminology Criteria for Adverse Events (CTCAE) version 3.0 and the European 
Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 version 3.0 [8, 9]. 
Both of these are validated instruments that have undergone extensive psychometric testing, 
and meet established standards for validity and reliability as detailed in the FDA Draft 
guidance for PROs [1, 10]. Patients completed the surveys preoperatively, and weekly during 
a 6-week postoperative period. Reminders to complete the reports were sent to participants 
via email.
Email alerts were also sent to the study nurses when concerning patient responses were 
entered. Alerts were considered concerning according to pre-specified limits set by the 
Gynecologic Oncology Service. This is the same system presently used to triage patient 
phone calls. Any actions taken by the nurses in response to these alerts were recorded. 
However, specific responses were not required. Patients were encouraged to call their 
physician’s office if medical attention was needed, as there was no regularly scheduled 
monitoring of information entered into the STAR system.
Patient and nurse assessments of STAR’s usefulness were measured via an exit survey. A 
“responder” was defined as a patient who logged in and completed at least half of the 
questionnaire, and participated in at least four of the seven potential login times.
RESULTS
Demographics
The study accrued 120 consecutive patients between July 2009 and January 2015. All 
participants were scheduled to undergo laparotomy for suspected or confirmed gynecologic 
malignancy. Twenty-four patients were eventually removed from the study, leaving 96 
eligible, evaluable patients (Figure 1). The median age was 55.5 (range 18–74). Table 1 
reports the demographic and clinical characteristics of the included patients.
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Intervention
Seventy-one patients (74%) completed at least four of seven surveys, and were therefore 
considered responders. Sixty-nine (63%) patients completed the preoperative session in 
STAR. The remaining patients did not complete the preoperative session, but did complete 
subsequent surveys. Nine (9%) patients completed only one survey. Similar to the pilot 
study, patient compliance gradually decreased as the postoperative period elapsed (Figure 2). 
There was no statistically significant difference in the demographic or clinical characteristics 
of responders versus non-responders.
Alerts
One hundred and twelve patient-reported symptoms generated an alert, resulting in 28 
contacts and two Emergency Department referrals. Overall, the CTC generated 81 individual 
episode alerts and the EORTC generated 31 episode alerts of 84 different symptoms. The 
most common CTC symptoms were poor performance status, nausea, and fatigue. The most 
common EORTC symptoms were difficulty with strenuous activity, constipation, and pain. 
Tables 2 and 3 show the distribution of all symptoms. Most alerts were read by a nurse 
within one day (mean 1, median 0 days). Ten alerts (12%) had already been addressed by a 
recent patient phone call or clinic visit. Three (4%) patients had already been scheduled for a 
clinic visit, during which the issue could be addressed. One (1%) patient was admitted while 
completing her survey, and her symptoms were addressed by the inpatient care team.
Patient Satisfaction
Fifty-one patients (46%) completed the exit satisfaction survey. Table 4 shows the patient 
satisfaction survey (excluding 7 patients who did not use the STAR system to record their 
symptoms). Ninety-eight percent found STAR easy to use, 84% found it useful, and 82% 
would recommend it to other patients. One patient reported,
“During acute phase of rehab, looked forward to reporting symptoms (in control of 
something that is otherwise not controllable) Questions prompted the patient to 
consider contacting office regarding symptoms. [I] was appreciative of nurse follow 
up for reported symptoms.”
Of the less satisfied participants, two comments explain the issues they had with the STAR 
system.
“Program too rigid. Questions didn’t account for actual conditions. Was contacted 
by nurses for symptom that is expected (fatigue). Seems irrelevant”
“Felt very isolated, the technology limits the communication as opposed to human 
to human interaction”
Seven patients did not use the system to record their symptoms. Five reported that they 
forgot to use it; 1 of those women also experienced technical difficulties because she could 
not get her user ID and password to work. Of the remaining 2 patients, 1 did not find it 
useful because she did not feel sick; the other patient did not give a reason for not using the 
system. One patient with poor compliance completed two of the seven CTC evaluations, 
reporting that,
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“Survey was the last thing I felt like doing.”
The most common suggestion made by the participants who filled out the satisfaction survey 
was to add a comment box to the CTC survey. One patient stated,
“A very big, big suggestion ……. the questions asked every week were good, 
however, the answers provided answers did not necessarily tell the exact truth 
because there were no comment sections that needed to explain further from the 
candid answer. There were many times that the answers provided were either black 
or white and did not allow the patient to elaborate. In fact when I had to answer one 
of the questions one of the weeks, I did not feel comfortable with picking any of the 
written answers because it did not describe what I was feeling at the time and 
because I had to pick one it seemed different from the way I was answering the 
questions in other weeks which prompted a call from the Surgeon’s nurse making 
sure I was ok …… I had to explain that there was no comment section to elaborate 
further how I was feeling because the blanket answers I had to use did not apply 
totally to the accuracy of my condition. Please add comment section below to each 
question.”
Another patient stated, similarly,
“No place to explain symptom attribution, wondered “Should I even tell them?” if 
the cause wasn’t surgery related…”
Clinician satisfaction
Nine nurses participated in the study, 3 of whom left the institution prior to the close of the 
study. Of the remaining 6 participating nurses, 4 completed the anonymous Clinician Exit 
Survey. Most nurses did not find STAR helpful. Seventy-five percent did not find the self-
assessments of pain and quality of life to be accurate. None of the nurses felt that the STAR 
system affected their ability to detect patient symptoms. All nurses surveyed reported that 
the STAR system increased their workload.
DISCUSSION
PRO metrics are practical, meaningful tools for documenting and tracking symptomatology 
and quality metrics. Such tools will become increasingly important as The Merit-Based 
Incentive Payment System (MIPS) & Alternative Payment Models (APMs) are incorporated 
into health care. This study demonstrated that the utilization of a Web-based program for 
capturing PROs in the postoperative setting, in patients recovering from major gynecologic 
surgery, is feasible and acceptable for most patients who have a computer and home internet 
access. Our patients reported a positive experience with the system and would recommend 
its use. The program helped many patients to feel more empowered in their postoperative 
recovery.
PROs in the immediate postoperative period can also be useful for improving symptom 
assessment. Recently, a report from MD Anderson Cancer Center (MDACC) evaluated the 
PROs of 29 gynecologic oncology patients undergoing laparotomy, using a paper and 
telephone version of the MDACC Symptom Inventory (MDASI-OC) [11]. They similarly 
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concluded that collecting PROs during the peri- and postoperative period is feasible. Pain 
and fatigue were among the most burdensome postoperative symptoms. This report was 
consistent with the pilot study showing poor performance status, nausea, and fatigue as the 
most common and distressing postoperative symptoms [7].
Our STAR system enhanced the patient experience; however, patients did not always feel 
that their symptoms could be adequately explained by the options given. Prior to 
implementation of an electronic PRO collecting system, patients should be involved in the 
development of a program that adequately reflects their symptomatology. Data from other 
surgical subspecialties have suggested that clinicians may underestimate patient symptoms 
[12, 13]. Seventy-five percent of our study nurses did not find the self-assessments accurate. 
As this was not an aim of the study, further research should be conducted to investigate the 
discordance between provider and patient perceptions of symptomatology.
In addition, our clinical staff did not find the information reported in the STAR system to be 
clinically useful. Therefore, we believe that providers should be involved in the development 
and implementation of such a system in order to appropriately incorporate it into current 
workflow, thus reducing—rather than adding to—burden. In 2013, Cook et al reported on 
their experience with an e-health platform in a population of postoperative cardiac patients. 
They also found the intervention to be feasible and effective; however, it did require 
increased nursing and ancillary staff input [14]. Some providers understand the benefit and 
importance of this type of outcome measure but share similar concerns, not only about the 
work required to implement such a system, but about receiving excessive information or 
diminishing the patient experience [15]. The best use of a system like this may be to 
facilitate patient empowerment and clinical research, in addition to or in lieu of 
postoperative symptom management. Symptom reports could also be summarized and 
printed for provider review prior to appointments, which could make postoperative 
appointments more efficient.
Interestingly, we found a difference in the quantity of alerts generated by the CTC and 
EORTC surveys. Despite being administered less frequently, EORTC generated more alerts 
than the CTC. Additionally, the distribution of certain symptoms, such as constipation and 
nausea, varied between the surveys. This could be related to the times at which these surveys 
were administered, or to the actual composition of the survey questions. The EORTC 
questionnaire is one of the most thoroughly tested tools among PRO measures in 
gynecologic oncology, demonstrating good reliability and validity [16]. The NCI CTCAE is 
the gold standard for assessing patient symptom severity, and has previously been used 
successfully in Web-based PRO reports [8]. It is possible that the CTC is better able to filter 
less severe symptomatology. Some patients did report feeling that they were contacted for 
“concerning symptoms” that were actually an expected aspect of the postoperative recovery 
process. Going forward, studies or clinical practices that make use of these tools may want 
to include a comment box in which patients can elaborate on the severity of their symptoms, 
and suggest whether or not urgent intervention is actually warranted.
The strengths of this study include its design as a large, prospective, longitudinal study of 
patients undergoing complex open gynecologic surgeries, using two validated PRO 
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questionnaires. This is one of few studies to report on PROs in the immediate postoperative 
period in this group of patients. The constructive feedback elicited from both patients and 
providers is one of the strengths of this study, and will facilitate modifications and 
opportunities to create a more efficient symptom management tool.
The STAR system has the potential for extrapolation to other major surgeries. Caution 
should be exercised for complete adoption, as this approach may require technology savvy 
on the part of patients. In our study over 50% of participants reported a college level degree 
or higher, which may have skewed adoption and participation. This is a significantly greater 
percentage of highly educated patients than has been reported in other gynecologic cancer 
populations [17]. Additionally, the economics of a home computer and internet access may 
limit applicability.
This study demonstrates that a Web-based platform can be used to collect and measure 
PROs in the immediate postoperative period, that patients are willing to self-report common 
postoperative symptoms, and that patients found this system useful. Additional work must 
be done to improve clinician satisfaction, and to determine the system’s usefulness and its 
optimal incorporation into clinical practice. Electronic methods of capturing PROs have also 
been reported in the inpatient setting, and in the use of mobile devices [14, 18]. Further 
research should focus on the utility of these interventions in assessing patient recovery after 
major gynecologic surgery.
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HIGHLIGHTS
1. A web-based model for assessing patient reported outcomes is feasible in the 
immediate postoperative period.
2. Many patients feel empowered by documenting and reporting PROs during 
the post-operative recovery period.
3. A Web-based system for capturing PROs may require additional resources for 
clinically useful application.
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Figure 1. Consort Diagram
Diagram demonstrates study accrual between July 2009 and January 2015, exclusion, and 
participation. All participants were scheduled to undergo laparotomy for suspected or 
confirmed gynecologic malignancy.
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Figure 2. 
Percentage of completed PRO surveys at each point, starting preoperatively to week 6
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Table 1
Patient Characteristics
Characteristics Number of patients (%)
N = 110
ASA Class
    II 51 (46)
    III 59 (54)
Surgical Procedures Performed
    Hysterectomy ± staging 76 (69)
    Resection of tumor 28 (25)
    Salpingo-oophorectomy 5 (5)
    Other 1 (1)
Disease Origin
    Ovary/Fallopian tubes 79 (72)
    Uterus 24 (22)
    Other 7 (6)
Final pathologic evaluation
    Malignancy 86 (78)
    Benign disease 19 (17)
    Borderline tumors 5 (5)
Internet use frequency
    More than once a week 85 (77)
    At least once a week 7 (6)
    Once a week 6 (5)
    Less than once a week 2 (2)
    Unknown 10 (9)
Email use frequency
    More than once a week 87 (79)
    At least once a week 7 (6)
    Once a week 5 (5)
    Less than once a week 1 (1)
    Unknown 10 (9)
Highest educational level
    Professional/graduate degree 29 (26)
    College degree 32 (29)
    Some college 18 (16)
    High school or less 8 (7)
    Unknown 23 (21)
Job status
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Cowan et al. Page 13
Characteristics Number of patients (%)
N = 110
    Employed 58 (53)
    Homemaker 11 (10)
    Retired 11 (10)
    Unemployed 5 (5)
    Other 3 (3)
    Unknown 22 (20)
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Table 2
CTC Symptoms
CTC Symptoms
81 alerts
N (%)
ECOG Performance Status 17 (15)
Nausea 16 (14)
Fatigue 13 (12)
Pain 9 (8)
Dyspnea 7 (6)
Wound complication 7 (6)
Fever 6 (5)
Palpitations 3 (3)
Constipation 1 (.04)
Diarrhea 1 (.04)
Urinary frequency 0 (0)
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Table 3
EORTC Symptoms
EORTC Symptom Alert
31 alerts, 84 symptoms
N(%)
Trouble with strenuous activities 14 (17)
Constipation 9 (11)
Pain 9 (11)
Trouble taking a long walk 8 (10)
Need rest 5 (6)
Worried 5 (6)
Limited in doing either work or other daily activities 4 (5)
Limited in pursuing hobbies or other leisure time activities 4 (5)
Diarrhea 3 (4)
Nausea 3 (4)
Pain interfered with daily activities 2 (2)
Short of breath 2 (2)
Felt weak 2 (2)
Felt tired 2 (2)
Felt tense 2 (2)
Felt irritable 2 (2)
Felt depressed 2 (2)
Felt physical condition or medical treatment caused you financial difficulties 2 (2)
Felt physical condition or medical treatment interfered with family life 1 (1)
Emesis 1 (1)
Trouble sleeping 1 (1)
Poor QOL 1 (1)
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Table 4
Patient Satisfaction Results
Question Response (percentage of patients)
N= 44 pts who completed
survey AND used system
Strongly
agree
Agree Disagree Strongly Disagree
I found the STAR easy to use. 73 25 2 0
I found the STAR to be useful. 25 59 14 2
I found it easy to login to the STAR. 39 34 5 0
I found it easy to enter my symptom information into the STAR. 43 43 11 2
I found the questions in the STAR easy to understand. 52 46 2 0
Using the STAR made it easier for me to remember my symptoms and side effects 
when I went to office visits.
16 57 25 2
Using the STAR improved discussions with my doctor/nurse. 11 55 27 2
My doctor/nurse used information from the STAR for my care. 20 41 23 2
The quality of my care was improved because of using the STAR. 14 36 42 2
Communication with my doctor/nurse was improved because of the STAR. 16 34 37 5
I would recommend the STAR to other patients. 27 55 11 2
I would like to continue using the STAR in the future. 20 52 20 5
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